Topical Anesthetic Use In Pessary Management



Status:Active, not recruiting
Conditions:Chronic Pain
Therapuetic Areas:Musculoskeletal
Healthy:No
Age Range:18 - Any
Updated:4/21/2016
Start Date:July 2015
End Date:December 2018

Use our guide to learn which trials are right for you!

Topical Anesthetic Use In Pessary Management: A Randomized Double Blinded Placebo Controlled Trial

The purpose of this study is to evaluate if lidocaine-prilocaine (EMLA 5%) cream can reduce
pain and discomfort at the time of vaginal pessary removal and insertion. Half of the
participants will receive lidocaine-prilocaine (EMLA 5%) cream and the other half will
receive a placebo cream.

Lidocaine-prilocaine (EMLA 5%) cream has been shown to be effective in reducing pain during
minor gynecologic procedures. The primary objective of this trial is to determine if the use
of 5% EMLA cream at the time of pessary removal and insertion reduces pain when compared to
the use of placebo cream.

Participants will be randomized to receive either 10 grams of 5% EMLA cream (4 mL) or 4 mL
of placebo cream (aqueous cream BP). Cream will be applied in office at the time of pessary
removal and insertion.

Inclusion Criteria:

- Women in the Loyola Urogynecology clinic who use a pessary for management of pelvic
organ prolapse (POP) or urinary incontinence (UI)

- Read and speak the English language

Exclusion Criteria:

- Non-English speaking

- Allergy or contraindication to topical anesthetic

- Participation/randomization in the study at a previous visit

- Currently pregnant or lactating or planning a pregnancy within the next 6 months
We found this trial at
1
site
2160 South 1st Avenue
Maywood, Illinois 60153
(888) 584-7888
Loyola University Medical Center Loyola University Health System is committed to excellence in patient care...
?
mi
from
Maywood, IL
Click here to add this to my saved trials